Dynamic Compliance-Guided Personalized PEEP During Laparoscopic Bariatric Surgery: Effects on Intraoperative Respiratory Parameters
1 other identifier
observational
40
1 country
1
Brief Summary
Atelectasis may be encountered in the patient population aged 18-65 years undergoing elective laparoscopic bariatric surgery under general anesthesia with endotracheal intubation. The aim of this study is to compare oxygenation, postoperative atelectasis, and postoperative respiratory complications between the fixed PEEP application (SP Group) and personalized PEEP application (KP Group). In the SP Group, ventilation will be applied with PEEP = 8 cmH2O, tidal volume = 8 ml/kg, and respiratory rate to maintain EtCO2 between 35-40, and this ventilation mode was maintained throughout the entire surgery. In the KP Group, ventilation was applied with tidal volume = 8 ml/kg, PEEP = 4 cmH2O, and respiratory rate to maintain EtCO2 between 35 -40, and dynamic compliance was noted 1 minute after the onset of pneumoperitoneum at 12 mmHg. Subsequently, the PEEP value wastitrated every 2 minutes by increasing it by 2 cmH2O until the level providing the highest dynamic compliance value is reached. If the dynamic compliance value does not increase in two consecutive measurements, the previous PEEP value was defined as the patient's "personalized PEEP" value, and ventilation was continued with this PEEP value until the end of the surgery. In all patients, arterial blood gas (ABG) was obtained 10 minutes after anesthesia induction, at the 10th and 30th minutes of pneumoperitoneum, and 10 minutes after pneumoperitoneum is terminated.Patients were transferred to the recovery room after anesthesia is discontinued, and arterial blood gas sampling and lung ultrasound was performed at 30 minutes postoperatively. On postoperative day 1, presence of atelectasis was assessed with lung ultrasound, and SpO2 was recorded at 4th, 12th, and 24th hours postoperatively. Within 4 hours postoperatively, patients in need of supplemental oxygen were recorded(SpO2 92% was decided as cut-off value). After the 4th hour, the number of patients requiring supplemental oxygen after the 4th hour was recorded and compared in both groups. Data were collected and recorded using a standardized paper-based data collection form. A power analysis measurement (post-hoc test) is planned to be performed. If the power analysis exceeds 80% between the groups, the study will be terminated. Data collection was completed after reaching the planned number of volunteers. The study results will be evaluated using the SPSS statistical analysis program. Numerical data between groups (SP vs. KP) will be evaluated using the ANOVA test or Kruskal Wallis test, while categorical data will be evaluated using the chi-square test or Fisher exact test. P\<0.05 will be considered statistically significant, and univariate and multivariate analyses will be performed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 10, 2025
CompletedFirst Submitted
Initial submission to the registry
January 7, 2026
CompletedFirst Posted
Study publicly available on registry
January 16, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 10, 2026
CompletedJanuary 16, 2026
January 1, 2026
11 months
January 7, 2026
January 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
LUSS score (lung ultrasound severity score)
Lung aeration was assessed using the Lung Ultrasound Score (LUS). Each lung was divided into six regions (anterior, lateral, and posterior areas, each subdivided into upper and lower regions), resulting in a total of 12 regions. Each region was scored from 0 to 3 based on ultrasound findings, with higher scores indicating greater loss of lung aeration. The total LUS ranged from 0 to 36.
6 months
compliance in individualized and non-individualized peep group
Compliance was assessed intraoperatively in both the individualized PEEP group and the non-individualized (fixed PEEP) group.In the individualized PEEP group, PEEP was titrated based on dynamic compliance, and respiratory system compliance was recorded at the PEEP level that yielded the highest dynamic compliance value for each patient.In the non-individualized PEEP group, a predefined fixed PEEP level was applied throughout the procedure, and respiratory system compliance was measured at this fixed PEEP level.
6 months
arterial blood gas analysis
Arterial blood gas analysis was performed to assess arterial oxygenation. The partial pressure of arterial oxygen (PaO₂) was recorded at predefined intraoperative time points and analyzed to determine significant differences between the individualized PEEP and fixed PEEP groups.
6 months
Study Arms (2)
SP-standard peep
individuals monitored by standard PEEP
KP-individualized peep
individuals monitored by individualized PEEP
Interventions
individuals were compared by using of a personalized peep or not
Eligibility Criteria
The study population consisted of adult women and men aged 18 to 65 years who were scheduled for elective laparoscopic bariatric surgery. Eligible participants had an American Society of Anesthesiologists (ASA) physical status of I-III and a body mass index (BMI) greater than 30 kg/m². All participants provided written informed consent prior to enrollment. Patients were excluded if they were younger than 18 years or older than 65 years, were not scheduled for bariatric surgery, had an ASA physical status of IV-V, or a BMI less than 30 kg/m². Additional exclusion criteria included refusal or inability to provide informed consent; a history of chronic obstructive pulmonary disease (COPD) classified as GOLD stage III or IV; severe or uncontrolled bronchial asthma; severe restrictive lung disease; a history of pulmonary metastases or previous thoracic surgery; the requirement for preoperative thoracic drainage; the need for preoperative renal replacement therapy; and congestive heart fail
You may qualify if:
- Adult women and men aged 18 to 65 years Scheduled for elective laparoscopic bariatric surgery American Society of Anesthesiologists (ASA) physical status I-III Body mass index (BMI) \> 30 kg/m² Provision of written informed consent
You may not qualify if:
- Age \< 18 years or \> 65 years Not scheduled for bariatric surgery ASA physical status IV-V Body mass index (BMI) \< 30 kg/m² Refusal or inability to provide inHistory of Chronic Obstructive Pulmonary Disease (GOLD III and IV) History of severe/uncontrolled bronchial asthma Severe restrictive lung disease History of pulmonary metastases History of thoracic surgery Requiring preoperative thoracic drainage Requiring preoperative renal replacement therapy Congestive heart failure (NYHA Class III and IV)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yeditepe University
Istanbul, Atasehir, Turkey (Türkiye)
Biospecimen
arterial blood gas
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 7, 2026
First Posted
January 16, 2026
Study Start
December 1, 2024
Primary Completion
November 10, 2025
Study Completion
April 10, 2026
Last Updated
January 16, 2026
Record last verified: 2026-01